Impact Series: Solving Medical Mysteries with Aperiomics

The BioScience Talks Impact Series focuses on the path from newly gained scientific knowledge to real-world effects, addressing questions such as How does a new vaccine find its way to physicians' offices? How do ecological discoveries result in new natural resource management paradigms? How do gene-editing techniques move from discovery to therapy? By following novel research discoveries from the lab and field to law books and store shelves, we find the answers and highlight the many ways that scientific research improves our lives. In this inaugural episode, we interviewed Dr. Crystal Icenhour, CEO of Aperiomics, a life sciences company located in Loudoun County, Virginia. The company uses a technique called shotgun metagenomic sequencing identify every known bacteria, virus, fungus, and parasite (over 37,000) found in a given patient sample. Through this revolutionary technique, they are able to identify pathogens that would escape detection using traditional means. We chatted about the technology itself, and just as important, the pathway from innovation to helping patients in need. Learn more about Aperiomics. Subscribe on iTunes. Subscribe on Stitcher. Catch up with us on Twitter..  

The BioScience Talks Impact Series focuses on the path from newly gained scientific knowledge to real-world effects, addressing questions such as How does a new vaccine find its way to physicians' offices? How do ecological discoveries result in new natural resource management paradigms? How do gene-editing techniques move from discovery to therapy? By following novel research discoveries from the lab and field to law books and store shelves, we find the answers and highlight the many ways that scientific research improves our lives.

In this inaugural episode, we interviewed Dr. Crystal Icenhour, CEO of Aperiomics, a life sciences company located in Loudoun County, Virginia. The company uses a technique called shotgun metagenomic sequencing identify every known bacteria, virus, fungus, and parasite (over 37,000) found in a given patient sample. Through this revolutionary technique, they are able to identify pathogens that would escape detection using traditional means. We chatted about the technology itself, and just as important, the pathway from innovation to helping patients in need.

 

© AIBS · All Rights Reserved